全文获取类型
收费全文 | 34602篇 |
免费 | 3550篇 |
国内免费 | 122篇 |
专业分类
耳鼻咽喉 | 283篇 |
儿科学 | 1305篇 |
妇产科学 | 864篇 |
基础医学 | 4719篇 |
口腔科学 | 690篇 |
临床医学 | 4649篇 |
内科学 | 7122篇 |
皮肤病学 | 707篇 |
神经病学 | 3507篇 |
特种医学 | 876篇 |
外国民族医学 | 4篇 |
外科学 | 4041篇 |
综合类 | 574篇 |
一般理论 | 35篇 |
预防医学 | 3333篇 |
眼科学 | 472篇 |
药学 | 2450篇 |
中国医学 | 23篇 |
肿瘤学 | 2620篇 |
出版年
2023年 | 287篇 |
2022年 | 431篇 |
2021年 | 868篇 |
2020年 | 697篇 |
2019年 | 1051篇 |
2018年 | 1163篇 |
2017年 | 899篇 |
2016年 | 944篇 |
2015年 | 1010篇 |
2014年 | 1303篇 |
2013年 | 1781篇 |
2012年 | 2266篇 |
2011年 | 2183篇 |
2010年 | 1364篇 |
2009年 | 1247篇 |
2008年 | 1931篇 |
2007年 | 1976篇 |
2006年 | 1822篇 |
2005年 | 1775篇 |
2004年 | 1659篇 |
2003年 | 1495篇 |
2002年 | 1377篇 |
2001年 | 627篇 |
2000年 | 563篇 |
1999年 | 561篇 |
1998年 | 374篇 |
1997年 | 284篇 |
1996年 | 257篇 |
1995年 | 255篇 |
1994年 | 228篇 |
1993年 | 215篇 |
1992年 | 375篇 |
1991年 | 353篇 |
1990年 | 350篇 |
1989年 | 324篇 |
1988年 | 309篇 |
1987年 | 298篇 |
1986年 | 303篇 |
1985年 | 285篇 |
1984年 | 231篇 |
1983年 | 206篇 |
1982年 | 196篇 |
1981年 | 170篇 |
1980年 | 122篇 |
1979年 | 147篇 |
1976年 | 146篇 |
1975年 | 123篇 |
1974年 | 133篇 |
1973年 | 141篇 |
1972年 | 119篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
52.
GABA RECEPTORS: AS COMPLEX AS ABC? 总被引:1,自引:0,他引:1
Graham A. R. Johnston 《Clinical and experimental pharmacology & physiology》1994,21(7):521-526
53.
54.
A L Hartley J M Birch P A McKinney V Blair M D Teare J Carrette J R Mann C A Stiller G J Draper H E Johnston et al. 《Journal of epidemiology and community health》1988,42(3):235-242
The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC) collected interview and medical information relating to the child's past medical experiences from parents of 555 children diagnosed with cancer and parents of 1110 unaffected matched controls. No significant associations emerged overall for ante-natal care, place and mode of delivery, length of gestation, birth weight, condition at birth, special care, neonatal procedures or breast-feeding. Few risk factors relating to previous illnesses and medication were found, although increasing numbers of illnesses appeared to be associated with an increased risk of childhood cancer, particularly acute lymphoblastic leukaemia. A highly significant excess of case children had not been immunised (p = 0.005). In general, these results indicate that past medical experiences have little influence on the development of cancer in children. 相似文献
55.
56.
57.
A visual word identification task was used to measure the type of selective attention that occurs spontaneously when there are multiple stimuli, all potentially relevant, and insufficient time to process each of them fully. This task presents two words simultaneously, one above the other, for 200 ms, and periodically requires the subject to identify either the upper or the lower word. We tested schizophrenic patients, manic-depressive patients, and normal controls under a baseline divided attention condition with no predictability and then introduced a degree of predictability into the upper location that normally results in selective attention to the lower nonpredictable location. In both the divided attention and the selective attention conditions, the schizophrenic group was just as accurate in identifying words as the other two groups, indicating no deficit in the rate of information processing. However, spontaneous selective attention under conditions of predictability was abnormal in the schizophrenic patients: They paid more attention to the predictable than to the nonpredictable source of information, consequently processing different, not less, information than normal subjects. Abnormal values on a ratio measure of selective attention occurred in 85% of the schizophrenic patients compared with only 30% of the manic-depressives and 20% of the normal subjects. 相似文献
58.
The effect of vitamin C nutriture on complement component C1q concentrations in guinea pig plasma 总被引:2,自引:0,他引:2
This study shows that guinea pigs fed 100 times the amount of vitamin C needed for growth and for prevention of scurvy have elevated levels of complement component C1q. C1q is a plasma protein rich in hydroxyproline, an amino acid whose biosynthesis requires ascorbate. C1q is essential for host defense against pathogens, both as a component of the classical complement pathway and as an opsonin in the phagocytosis process. We measured C1q in vitamin C-depleted guinea pigs that had been repleted for 4 wks with the following daily doses of ascorbate (mg/100 g body wt): 0.50 (suboptimal), 2.0 (adequate), 10 (ample) and 50 (tissue saturating). We measured C1q in three ways: indirectly by quantifying protein-bound hydroxyproline and directly by hemolytic assay and by immunodiffusion against anti-C1q. Regardless of the method, plasma C1q was 30-50% higher in animals fed tissue-saturating ascorbate than in those fed adequate or suboptimal amounts of the vitamin (p less than 0.05, one-way analysis of variance, least significant difference test). These data confirm and significantly extend earlier work that provided indirect evidence for a relationship between C1q and ascorbate nutriture in the guinea pig. They are consistent with a possible relationship between ascorbate nutriture and host defense. 相似文献
59.
Emilie Balasse Gregory Gatouillat Dominique Patigny Marie Christine Andry Claudie Madoulet 《Vaccine》2009
Malignant melanoma causes significant health problems. The identification of tumour-associated antigens has led to novel approaches to increase T cell mediated anti-tumour immune response. Melan-A/MART-1 has been use as target antigen for several T cell based immunotherapeutic treatments. More recently, the critical role of CD4+ T cells in inducing and maintaining anti-tumour immunity has been increasingly recognized. In order to optimize tumour immunotherapy, greater efforts have been concentrated on the identification of tumour antigens presented by MHC class II molecules to CD4+ T cells. In a publication, Tiwari et al. (2004) [1] have identified by a computational approach the 15-mer amino-acid sequence 101–115 (PPAYEKLSAEQSPPP) of the Melan-A/MART-1 as a good target for a vigorous and safe immunotherapy. Therefore, we have investigated the in vivo anti-tumour activity of this peptide in a murine melanoma model. For the prophylactic treatment, 20 μg or 50 μg peptide was subcutaneously injected in mice once a week during 3 weeks before tumour induction. Treatment with 50 μg peptide significantly affected tumour development. Thus, our preliminary data demonstrate potential in vivo prophylactic activity of the 101–115 peptide-based vaccine to control melanoma growth. 相似文献
60.